The latest closing stock price for Apogee Therapeutics as of November 20, 2024 is 45.04.
An investor who bought $1,000 worth of Apogee Therapeutics stock at the IPO in 2023 would have $1,122 today, roughly 1 times their original investment - a 112.15% compound annual growth rate over 1 years.
The all-time high Apogee Therapeutics stock closing price was 69.80 on March 13, 2024.
The Apogee Therapeutics 52-week high stock price is 72.29, which is 60.5% above the current share price.
The Apogee Therapeutics 52-week low stock price is 16.39, which is 63.6% below the current share price.
The average Apogee Therapeutics stock price for the last 52 weeks is 45.47.
An investor who bought $1,000 worth of Apogee Therapeutics stock at the IPO in 2023 would have $1,122 today, roughly 1 times their original investment - a 112.15% compound annual growth rate over 1 years.
The all-time high Apogee Therapeutics stock closing price was 69.80 on March 13, 2024.
The Apogee Therapeutics 52-week high stock price is 72.29, which is 60.5% above the current share price.
The Apogee Therapeutics 52-week low stock price is 16.39, which is 63.6% below the current share price.
The average Apogee Therapeutics stock price for the last 52 weeks is 45.47.